Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer - Douillard, JY; Siena, S; Cassidy, J; Tabernero, J; Burkes, R; Barugel, M (Ann Oncol, 2014)